Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Cash from Financing Activities (2023)

Bluejay Diagnostics (BJDX) has disclosed Cash from Financing Activities for 1 consecutive years, with -$3050.0 as the latest value for Q4 2023.

  • Quarterly Cash from Financing Activities changed N/A to -$3050.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2023, changed N/A year-over-year, with the annual reading at $7.1 million for FY2025, 30.63% down from the prior year.
  • Cash from Financing Activities hit -$3050.0 in Q4 2023 for Bluejay Diagnostics, down from $1.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.2 million in Q3 2023 to a low of -$58803.0 in Q1 2023.